Zhejiang Zhenyuan Share Co Ltd - Asset Resilience Ratio

Latest as of March 2022: 5.75%

Zhejiang Zhenyuan Share Co Ltd (000705) has an Asset Resilience Ratio of 5.75% as of March 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read total liabilities of Zhejiang Zhenyuan Share Co Ltd for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥170.00 Million
≈ $24.88 Million USD Cash + Short-term Investments

Total Assets

CN¥2.96 Billion
≈ $432.55 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (1997–2021)

This chart shows how Zhejiang Zhenyuan Share Co Ltd's Asset Resilience Ratio has changed over time. See Zhejiang Zhenyuan Share Co Ltd (000705) shareholders funds for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Zhejiang Zhenyuan Share Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Zhejiang Zhenyuan Share Co Ltd worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥170.00 Million 5.75%
Total Liquid Assets CN¥170.00 Million 5.75%

Asset Resilience Insights

  • Limited Liquidity: Zhejiang Zhenyuan Share Co Ltd maintains only 5.75% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Zhejiang Zhenyuan Share Co Ltd Industry Peers by Asset Resilience Ratio

Compare Zhejiang Zhenyuan Share Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
AstraZeneca PLC
NASDAQ:AZN
Drug Manufacturers - General 5.03%
Novartis AG
MX:NVSN
Drug Manufacturers - General 0.09%
Novartis AG ADR
NYSE:NVS
Drug Manufacturers - General 10.03%
Pfizer Inc
SA:PFIZ34
Drug Manufacturers - General 7.18%
Virbac SA
PA:VIRP
Drug Manufacturers - General 0.23%
Yifan Xinfu Pharmaceutical Co Ltd
SHE:002019
Drug Manufacturers - General 0.53%
Firebrick Pharma Ltd
AU:FRE
Drug Manufacturers - General 0.29%
Eli Lilly and Company
SA:LILY34
Drug Manufacturers - General 8.63%

Annual Asset Resilience Ratio for Zhejiang Zhenyuan Share Co Ltd (1997–2021)

The table below shows the annual Asset Resilience Ratio data for Zhejiang Zhenyuan Share Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2021-12-31 7.37% CN¥220.00 Million
≈ $32.19 Million
CN¥2.99 Billion
≈ $437.00 Million
+1.81pp
2020-12-31 5.55% CN¥150.00 Million
≈ $21.95 Million
CN¥2.70 Billion
≈ $395.28 Million
-4.10pp
2019-12-31 9.66% CN¥250.00 Million
≈ $36.58 Million
CN¥2.59 Billion
≈ $378.79 Million
+8.68pp
2015-12-31 0.98% CN¥19.00 Million
≈ $2.78 Million
CN¥1.94 Billion
≈ $283.62 Million
-4.60pp
2000-12-31 5.58% CN¥40.00 Million
≈ $5.85 Million
CN¥716.33 Million
≈ $104.82 Million
+3.79pp
1999-12-31 1.79% CN¥10.00 Million
≈ $1.46 Million
CN¥557.35 Million
≈ $81.56 Million
-5.45pp
1998-12-31 7.24% CN¥40.00 Million
≈ $5.85 Million
CN¥552.33 Million
≈ $80.82 Million
+2.24pp
1997-12-31 5.00% CN¥28.00 Million
≈ $4.10 Million
CN¥559.86 Million
≈ $81.93 Million
--
pp = percentage points

About Zhejiang Zhenyuan Share Co Ltd

SHE:000705 China Drug Manufacturers - General
Market Cap
$403.85 Million
CN¥2.76 Billion CNY
Market Cap Rank
#13636 Global
#4307 in China
Share Price
CN¥8.26
Change (1 day)
+0.24%
52-Week Range
CN¥7.95 - CN¥10.55
All Time High
CN¥18.44
About

Zhejiang Zhenyuan Share Co.,Ltd. engages in the manufacture and wholesale of pharmaceutical products in China and internationally. Its products include Chinese herbal medicines and slices, Chinese patent medicines, chemical raw materials, chemical preparations, antibiotics, biochemical drugs, biological products, medical devices, chemical reagents, glass instruments, etc. The company also provide… Read more